Compare Dolby Laboratories, Inc. (DLB) vs Schwab US Large Cap Growth ETF (SCHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dolby Laboratories, Inc. vs Schwab US Large Cap Growth ETF — how do they compare? Dolby Laboratories, Inc. trades at $58.74 (market cap $5.47B), while Schwab US Large Cap Growth ETF trades at $36.74 (market cap $65.01B). The key difference: Schwab US Large Cap Growth ETF is far larger — about 11.9× Dolby Laboratories, Inc.'s market cap, and Dolby Laboratories, Inc. pays a 2.46% dividend while Schwab US Large Cap Growth ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dolby Laboratories, Inc. for 98 Days and Schwab US Large Cap Growth ETF for 50 Days on average.
| DLB | SCHG | |
|---|---|---|
Market Cap | $5.47B | $65.01B |
Volume | 1,058,284 | 8,554,399 |
Sector | Technology | Sector/Thematic |
52-Week High | $70.09 | $36.93 |
52-Week Low | $48.51 | $28.10 |
Typical Hold Time | 98 Days | 50 Days |
Enterprise Value | $4.85B | — |
Dividend Yield | 2.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DLB trades at $58.74, up 0.67% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue has been stable around $1.3B, with a net income margin of 18.9% in 2025. Recent news highlights expansion of Dolby Atmos and Vision with Meta and a leadership transition to Marc Whitten.
The outlook is mixed, with a consensus analyst price target of $90.33 suggesting significant upside, but technical indicators and a projected net cash flow decline in 2026 pose risks. Investment opportunities lie in the company's high gross margins and strategic partnerships, while risks include execution challenges and market volatility.
SCHG trades at $36.74, down 0.35% on the day, with a bullish technical signal from moving averages and neutral oscillators. The ETF maintains strong institutional interest despite a recent position reduction by Corient Private Wealth. Recent news highlights SCHG's low 0.03% expense ratio and its focus on large-cap growth stocks, though concentration in top holdings remains a structural consideration.
The outlook for SCHG remains positive given its growth orientation and cost efficiency, though investors should monitor concentration risks in top holdings. Market leadership in growth sectors and competitive fees support long-term potential, while sensitivity to tech sector volatility presents the primary near-term risk.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →About Schwab US Large Cap Growth ETF
SCHG is an ETF that seeks to track the total return of the Dow Jones U.S. Large-Cap Growth Total Stock Market Index. The fund provides low-cost exposure to a diversified portfolio of large-capitalization U.S. companies that are classified as growth stocks based on factors such as sales, earnings, and book value growth rates. SCHG is often used by investors seeking long-term capital appreciation from market-leading companies with above-average growth potential.
Read more on SCHG →
